Michael P. Cooke, Chief Scientific Officer at Magenta Therapeutics, Inc. (MGTA), sold 5,000 shares at $10.01 ($50K) on 2019-10-01, disclosed to the SEC on 2019-10-03.
Open-market sale of $50k MGTA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MGTA | SELL | 2019-11-01 | $53K | — | Filing → |
| MGTA | SELL | 2019-09-19 | $20K | — | Filing → |
| MGTA | SELL | 2019-09-16 | $10K | — | Filing → |